BioNTech Halted a Cancer Vaccine Trial, and Genentech Says There Were More Deaths in the Vaccine Group

BioNTech terminated a Phase 2 mRNA cancer vaccine trial in colorectal cancer after monitors found a survival imbalance between the two arms.

Have A Referral?